Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
SAGE Therapeutics ( (SAGE) ) just unveiled an update.
Sage Therapeutics, Inc. has announced a strategic reorganization involving the departure of key executives, including CFO Kimi Iguchi and General Counsel Anne Marie Cook. Their separation agreements offer continued salary, healthcare coverage, and bonuses, while Iguchi will also consult until March 2025. Both executives have adjusted stock options, emphasizing the company’s focus on restructuring and operational efficiency, a move closely watched by investors and market analysts.
Find detailed analytics on SAGE stock on TipRanks’ Stock Analysis page.